Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Phase 1 Clinical Trial of Myogenic Progenitors for DMD
Kang, P. B., Cheng, E. Y., Karachunski, P. I., McKenna, D. H., Perlingeiro, R. & Wagner, J. E.
7/1/23 → 6/30/26
Project: Research project
-
Foundations for a Phase 1 clinical trial of cell-based therapy for Duchenne muscular dystrophy
Kang, P. B., Karachunski, P. I., Perlingeiro, R. & Wagner, J. E.
NIH NIAMS NATL INST OF ARTHRIT
7/15/22 → 6/30/24
Project: Research project
-
A comprehensive study of skeletal muscle imaging in FHL1-related reducing body myopathy
Mohassel, P., Yun, P., Syeda, S., Batra, A., Bradley, A. J., Donkervoort, S., Monges, S., Cohen, J. S., Leung, D. G., Munell, F., Ortez, C., Sánchez-Montáñez, A., Karachunski, P., Brandsema, J., Medne, L., Chaudhry, V., Tasca, G., Foley, A. R., Udd, B., Arai, A. E., & 2 others , Aug 2023, In: Annals of Clinical and Translational Neurology. 10, 8, p. 1442-1455 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Systemic under treatment of heart disease in patients with Duchenne muscular dystrophy
Karachunski, P. & Townsend, D. W., Oct 2023, In: Neuromuscular Disorders. 33, 10, p. 776-781 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Anti-MDA5 juvenile idiopathic inflammatory myopathy with second-degree heart block but no skin or lung involvement: a case report
Ryan, M. E., Cortez, D., Dietz, K. R., Karachunski, P. & Binstadt, B. A., Dec 2021, In: BMC Rheumatology. 5, 1, 8.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Corrigendum to “Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy” [Neuromuscular Disorders, Vol. 30 (6) 2020, 492-502] (Neuromuscular Disorders (2020) 30(6) (492–502), (S0960896620301188), (10.1016/j.nmd.2020.05.002))
Wagner, K. R., Abdel-Hamid, H. Z., Mah, J. K., Campbell, C., Guglieri, M., Muntoni, F., Takeshima, Y., McDonald, C. M., Kostera-Pruszczyk, A., Karachunski, P., Butterfield, R. J., Mercuri, E., Fiorillo, C., Bertini, E. S., Tian, C., Statland, J., Sadosky, A. B., Purohit, V. S., Sherlock, S. P., Palmer, J. P., & 4 others , Feb 2021, In: Neuromuscular Disorders. 31, 2, p. 167-168 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access8 Scopus citations -
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy
Shieh, P. B., Elfring, G., Trifillis, P., Santos, C., Peltz, S. W., Parsons, J. A., Apkon, S., Darras, B. T., Campbell, C., McDonald, C. M., Barohn, R. J., Bertini, E., Bushby, K., Chabrol, B., Ciafaloni, E., Columer, J., Comi, G. P., Connolly, A., Finkel, R. S., Flanigan, K. M., & 88 others , Dec 1 2021, In: Journal of Comparative Effectiveness Research. 10, 18, p. 1337-1347 11 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations